Show notes
The dapivirine vaginal ring holds promise in the fight against HIV. But for the young women in Africa who need it most, access remains a major challenge. Women aged 15 to 24 are disproportionately vulnerable to HIV infection due to a complex web of factors, including social, cultural, and economic forces. The silicone ring reduces their risk of infection by continually releasing the antiretroviral dapivirine into the vagina. In this episode of Africa Science Focus, rep...

